Breast Tissue Markers Market Report 2026

Breast Tissue Markers Market Overview

• Breast Tissue Markers market size has reached to $2.99 billion in 2025 • Expected to grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Growth Of The Breast Tissue Marker Market Driven By Increasing Breast Cancer Cases • Market Trend: Innovative Breast Biopsy Site Markers Enhance Visibility And Stability In Surgical Procedures • North America was the largest region in 2025.

What Is Covered Under Breast Tissue Markers Market?

Breast tissue markers are small, implantable devices used in breast cancer diagnosis and treatment to mark the location of a biopsy site, tumor, or area of concern within the breast tissue. These markers are typically placed during a biopsy procedure to ensure accurate identification of the site for future imaging, surgery, or treatment. The main product types of breast tissue markers are metal and non-metal. Metal breast tissue markers are small markers made from metal materials, such as stainless steel, used to accurately identify and monitor breast tumors. The materials are non-biodegradable and partially biodegradable, and the shapes are coil, ribbon, butterfly, V-shape, and others. It is used by various end-users, such as hospitals, ambulatory, surgical centers, diagnostic centers, and specialty clinics.

What Is The Breast Tissue Markers Market Growth Forecast?

The breast tissue markers market size is expected to see strong growth in the next few years. It will grow to $4.43 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to development of polymer-based and gelatin markers, expansion of minimally invasive biopsy procedures, rising investment in imaging-compatible tissue markers, increasing awareness of patient safety and marker biocompatibility, integration of tissue markers with advanced imaging systems. Major trends in the forecast period include increasing adoption of metal and non-metal tissue markers, rising preference for biodegradable and radiopaque markers, growth in breast cancer screening and biopsy procedures, demand for shape-specific markers for accurate localization, enhanced focus on imaging compatibility and patient safety.

Global Breast Tissue Markers Market Segmentation

1) By Product: Metal, Non-metal 2) By Material: Non-biodegradable, Partially Biodegradable 3) By Shape: Coil, Ribbon, Butterfly, V-Shape, Other Shapes 4) By End-user: Hospitals, Ambulatory, Surgical Centers, Diagnostic Centers, Specialty Clinics Subsegments: 1) By Metal: Titanium Markers, Stainless Steel Markers, Gold Markers 2) By Non-Metal: Biodegradable Markers, Radiopaque Markers, Polymer-Based Markers, Gelatin Markers

What Is The Driver Of The Breast Tissue Markers Market?

The rise in the number of breast cancer cases is expected to propel the growth of the breast tissue markers market going forward. Breast cancer is a malignant tumor that originates in the cells of the breast tissue. The rise in breast cancer cases is often attributed to factors such as increased life expectancy, improved detection methods, lifestyle changes, and environmental influences. Breast tissue markers are used in breast cancer to help diagnose, track disease progression, and guide treatment decisions by identifying specific proteins or genetic mutations. For instance, in October 2025, according to Breastcancer.org, a US-based non-profit organization, reported that in 2025, an estimated 316,950 women will be diagnosed with invasive breast cancer, along with about 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Therefore, the rise in the number of breast cancer cases is driving the growth of the breast tissue markers industry.

Key Players In The Global Breast Tissue Markers Market

Major companies operating in the breast tissue markers market are Johnson & Johnson Company, Medtronic PLC, Hologic Inc., Cook Medical Inc., Merit Medical Systems Inc., Argon Medical Devices Inc., Devicor Medical Products Inc., Endomag, Becton Dickinson and Company, INRAD Inc., Biopsy Sciences LLC, Carbon Medical Technologies Inc., Scion Medical Technologies LLC, SOMATEX Medical Technologies GmbH, Seno Medical Instruments Inc, Sterylab S.r.l., Biopsybell S.r.l., MDL S.r.l., SenoRx Inc, Elucent Medical, Cortex, Medax Medical Devices, Tsunami S.r.l., Ranfac Corp

Global Breast Tissue Markers Market Trends and Insights

Major companies operating in the breast tissue markers market are focusing on developing innovative solutions, such as breast biopsy site markers, to enhance ultrasound visibility, improve ease of locating, and mitigate displacement during surgical procedures. A breast biopsy site marker is a small device placed at the biopsy site to mark the location for future imaging or surgical procedures. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy markers, introduced the HydroMARK Plus breast biopsy site marker. This marker features a hydrogel design that expands upon contact with fluid, enhancing visibility in ultrasound imaging. Its innovative design ensures precise site marking and accurate localization for subsequent diagnostic and treatment procedures. Additionally, it provides long-term stability within breast tissue, minimizing the need for further interventions.

What Are Latest Mergers And Acquisitions In The Breast Tissue Markers Market?

In July 2024, Hologic Inc., a US-based health technology company, acquired Endomagnetics Ltd. for an undisclosed amount. This acquisition allows Hologic to enhance its breast cancer diagnostics and treatment offerings by integrating Endomagnetics' advanced magnetic detection technologies. Endomagnetics Ltd. is a UK-based provider of breast tissue markers.

Regional Outlook

North America was the largest region in the breast tissue markers market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Breast Tissue Markers Market?

The breast tissue markers consist of sales of radiofrequency identification (RFID) markers, magnetic markers, ultrasound-visible markers, and hydrogel markers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.